key: cord-0045400-idp523sl
authors: Boelig, Rupsa C.; Bellussi, Federica; Berghella, Vincenzo
title: REPLY to: Labor and Delivery Guidance for COVID-19
date: 2020-06-15
journal: Am J Obstet Gynecol MFM
DOI: 10.1016/j.ajogmf.2020.100158
sha: 87d618bb5686a25d84ba71c7730d6e3c3a2235c8
doc_id: 45400
cord_uid: idp523sl

nan

The authors report no conflict of interest. Thank you for your interest and inquiry. We apologize that the appropriate references were not 20 included in our manuscript. There are a number of different publications that have demonstrated 21 aerosolization with cough, many are summarized in a recent commentary which we had intended 22 to include as the reference (1). We have listed some key references below identifying 23 aerosolization in cough (2-7). In addition, it is important to consider that aerosolization in setting 24 of disease transmission is not equivalent across all disease but that does not mean it is non- More importantly and to your point of limited resources; this is certainly an important balance 32 that each healthcare system must make. Things to consider include ability to test for COVID, 33 there is now rapid testing available that would allow for testing of all admissions to labor and 34 delivery so that you could reserve use of limited PPE for those that are truly COVID positive and 35 have the reassurance that other laboring patients are in fact COVID negative and not COVID 36 unknown due to lack of testing. All forms are PPE are risk reducing and not risk eliminating. We 37 present what best practices should be and recognize that in the real world with limited resources 38 best practices may not always be possible. We strive to advocate, and to provide data to support, 39 policies that will not just promote patient safety but also a safe work environment for healthcare 40 providers.

The second stage of labor presents a unique clinical scenario of very close contact (<6 feet) with 42 deep and heavy breathing in a patient who, even if she has a mask to wear, may have trouble 43 keeping it on, and thus is a scenario where aerosoles are produced and disseminated close contact 44 (3). In the setting of a pandemic it is important to consider not just PPE as a limited resource, but 45 our healthcare workers as well. We, as others, continue to advocate for the consideration of the 46 second stage as a high risk scenario for both droplet and aerosole transmission and advocate that 47 the healthcare workers should be adequately protected (11-14) . 

Commentary: COVID-19 transmission messages should hinge on science

The size and concentration of droplets generated by 57 coughing in human subjects

Influenza virus aerosols in human exhaled 59 breath: particle size, culturability, and effect of surgical masks

Quantity and size distribution of cough-62 generated aerosol particles produced by influenza patients during and after illness

Measurements of airborne influenza virus 65 in aerosol particles from human coughs

Detection of infectious influenza virus in 67 cough aerosols generated in a simulated patient examination room

Measurement of airborne influenza virus in 70 a hospital emergency department

Recognition of aerosol transmission of 72 infectious agents: a commentary

Aerosol transmission is an important mode of 74 influenza A virus spread

Aerosol and surface stability of 76

HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. medRxiv

Now! Protection for obstetrical providers and patients

COVID-19 in pregnancy: early lessons. AJOG MFM

COVID-19 infection among asymptomatic and symptomatic pregnant 83 women: Two weeks of confirmed presentations to an affiliated pair of New York City 84 hospitals. AJOG MFM, in press

L&D guidance for COVID19. AJOG MFM